Last year, MRL promoted her co-partner, Peter Dudek, to president and managing partner of the $500m CVC unit.
Vertex Ventures HC, a US-based venture capital firm, has hired Christine Brennan from MRL Venture Funds, the pharma-focused corporate venturing unit of US-listed drugs company Merck.
Brennan is now a managing director alongside Lori Hu in co-leading Vertex Ventures HC, an independent healthcare-focused venture fund within the worldwide Vertex Ventures fund network anchored by Singapore state-backed Temasek.
Hu said: “Her successful track record as a biotech investor, chief business officer and board member will be incredibly valuable as we evaluate new opportunities and…
